Gothenburg, Sweden, June 3, 2026 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, announces that CEO Kristina Torfgård and CFO Gustaf Albèrt will participate in Aktiespararna’s event Aktiedagarna in Stockholm.
IRLAB’s presentation will take place on Tuesday, June 9, 2026, at 16:25 and will be broadcast live via the following link: https://www.aktiespararna.se/aktiviteter/aktiedagarna-i-stockholm-68173. It will also be available afterwards on the company’s website, www.irlab.se.
Aktiedagarna is an investor event organized by Aktiespararna and will be held at Birger Jarl Conference in Stockholm on June 9–10. The event is a hybrid meeting that brings together investors, companies, and industry experts, and can be attended both in person and digitally.